Wismilak Inti Makmur (WIIM) Stock Investment: Key Advantages and Risks for Investors

Wismilak Inti Makmur Stock (WIIM) 2026: Financial Analysis, Dividend Outlook, Risks, and Investment Case

PT Wismilak Inti Makmur Tbk (IDX: WIIM)

Worldreview1989 - PT Wismilak Inti Makmur Tbk (IDX: WIIM) is a relatively small Indonesian tobacco company that has attracted investor attention because of its combination of earnings growth, improving profitability, and dividend payments.

For U.S. investors, however, WIIM requires a different analytical framework from a typical U.S. consumer-staples stock. The company operates primarily in Indonesia, reports in Indonesian rupiah, sells cigarettes and tobacco-related products, and is subject to Indonesia's excise-tax and tobacco regulations.

The latest audited financial statements show a significant improvement in 2025. Net sales increased to Rp6.38 trillion, while net income attributable to the parent company's shareholders reached Rp419.2 billion, up sharply from 2024. The company also approved a Rp104.4-per-share cash dividend for fiscal 2025.

The key question for investors is therefore not simply whether Wismilak is profitable. The more important question is whether its 2025 growth can be sustained in an industry facing high tobacco taxes, regulatory pressure, changing consumer behavior, and long-term public-health concerns.

Wismilak Inti Makmur at a Glance

Company: PT Wismilak Inti Makmur Tbk
Ticker: WIIM
Exchange: Indonesia Stock Exchange (IDX)
Industry: Tobacco and cigarette manufacturing
Headquarters: Surabaya, Indonesia
Primary reporting currency: Indonesian rupiah (IDR)

Wismilak was established in 1963 and operates primarily in Indonesia's cigarette market. Its business includes cigarette manufacturing as well as tobacco-related products and filter production.

For an American investor, the company is best viewed as a small-cap emerging-market tobacco investment, rather than as a direct equivalent of Philip Morris International, Altria, or British American Tobacco.

The difference matters because WIIM has considerably greater exposure to Indonesia-specific regulatory, currency, liquidity, and political-economic risks.

2025 Financial Performance: A Major Rebound

Wismilak's 2025 financial results represent a significant improvement over 2024.

According to the company's audited consolidated financial statements, net sales increased from approximately Rp4.75 trillion in 2024 to Rp6.38 trillion in 2025. Gross profit increased from approximately Rp1.07 trillion to Rp1.41 trillion. Operating income increased from Rp376.4 billion to Rp556.8 billion.

Key Financial Metrics

Metric	FY2024	FY2025	Change
Net sales	Rp4.75T	Rp6.38T	+34.3%
Gross profit	Rp1.07T	Rp1.41T	+31.3%
Operating income	Rp376.4B	Rp556.8B	+47.9%
Net income attributable to parent	Rp298.7B	Rp419.2B	+40.3%
Total assets	Rp3.03T	Rp3.21T	+5.9%
Total equity	Rp1.92T	Rp2.21T	+15.6%

The company itself reported 2025 net sales of approximately Rp6.3817 trillion, compared with Rp4.7509 trillion in 2024, representing approximately 34% growth.

This is particularly important because 2024 was a difficult year for the company. Wismilak's 2024 annual report showed net sales declining 2.54%, while net income fell nearly 40% from 2023.

The 2025 results therefore represent more than ordinary incremental growth. They show a meaningful recovery in both revenue and profitability.

Profit Margins Are Improving

One of the strongest arguments in favor of WIIM is that earnings growth was accompanied by operating leverage.

Based on the audited numbers:

2025 gross margin

Rp1.408 trillion ÷ Rp6.382 trillion = approximately 22.1%

2025 operating margin

Rp556.8 billion ÷ Rp6.382 trillion = approximately 8.7%

2025 net margin

Rp419.2 billion ÷ Rp6.382 trillion = approximately 6.6%

The improvement is important because revenue growth without margin expansion would provide a weaker investment thesis.

Wismilak's operating income increased approximately 48% while revenue increased approximately 34%. That indicates that the company converted a portion of its additional sales into disproportionately higher operating profit.

What Drove the Revenue Growth?

The company's 2025 sustainability report provides useful segment information.

Wismilak reported strong growth in several product categories, including machine-rolled cigarettes and filter products. Its 2025 cigarette sales volume reached approximately 10.4 billion cigarettes, compared with 8.63 billion in 2024.

The company's reported revenue by major product category included approximately:

Machine-rolled cigarettes (SKM): Rp4.05 trillion
Hand-rolled cigarettes (SKT): Rp873.2 billion
Filter products: approximately Rp1.42 trillion
Cigar and other products: smaller contributions

The SKM segment was particularly important, with reported revenue increasing substantially year over year.

For investors, this suggests that Wismilak's 2025 performance was not simply the result of accounting effects. There was significant underlying growth in its core cigarette business.

Earnings Per Share

Wismilak reported basic earnings per share attributable to the parent company's shareholders of approximately Rp201.77 in 2025, compared with Rp143.89 in 2024.

That represents an increase of roughly:

(201.77 − 143.89) ÷ 143.89 ≈ 40.2%

This closely matches the growth in attributable net income.

For investors, EPS growth is more useful than headline revenue growth because ultimately the value of a stock depends on the earnings and cash flows available to shareholders.

Balance Sheet: Relatively Conservative Leverage

Wismilak ended 2025 with:

Total assets: approximately Rp3.21 trillion
Total liabilities: approximately Rp990.3 billion
Total equity: approximately Rp2.21 trillion
Cash and cash equivalents: approximately Rp335.8 billion

The company's reported debt-to-equity ratio was 0.45x, down from 0.58x in 2024.

This is a positive signal.

A 0.45x debt-to-equity ratio does not indicate an aggressively leveraged balance sheet. In an industry exposed to taxation, commodity costs, and regulatory changes, maintaining moderate leverage provides additional financial flexibility.

However, investors should distinguish between total liabilities and interest-bearing debt. Wismilak's balance sheet contains trade payables and other operating liabilities that are not equivalent to bank debt.

Liquidity Looks Comfortable

Wismilak's current assets were approximately Rp2.48 trillion against current liabilities of approximately Rp944.3 billion at the end of 2025.

That produces a current ratio of approximately:

Rp2.48T ÷ Rp944.3B = 2.63x

A current ratio above 2x provides a reasonable liquidity cushion.

However, there is an important caveat.

The largest current asset was inventory, at approximately Rp1.83 trillion.

That means investors should not treat the entire current-asset balance as equivalent to cash.

For a tobacco manufacturer, large inventories are understandable because the company needs raw materials and finished products. Nevertheless, inventory turnover and working-capital management should remain important items to monitor.

Cash Flow Is Improving — But Investors Should Watch Capital Spending

Wismilak generated approximately Rp362.5 billion in operating cash flow in 2025, compared with Rp156.9 billion in 2024.

That represents growth of more than 130%.

This is one of the more encouraging aspects of the 2025 results.

Net income attributable to shareholders was approximately Rp419.2 billion, while operating cash flow was approximately Rp362.5 billion.

The company also spent approximately Rp108.6 billion on property, plant and equipment and Rp114.6 billion on advances for the purchase of property, plant and equipment.

Therefore, investors should not focus exclusively on reported earnings. A more conservative analysis should also consider how much cash remains after capital expenditures.

Using operating cash flow less property, plant and equipment purchases as a simple approximation:

Rp362.5B − Rp108.6B ≈ Rp253.9B

This is not the same as formally calculated free cash flow because it excludes other investment-related cash movements, but it provides a useful indication that operating cash generation was substantial relative to capital expenditure.

Dividend Analysis

Income investors may find WIIM particularly interesting.

For fiscal 2025, shareholders approved a cash dividend of approximately Rp217.87 billion, equivalent to Rp104.4 per share. The dividend was scheduled for payment on June 12, 2026.

The company's attributable 2025 net income was approximately Rp419.21 billion.

That means the dividend payout ratio was approximately:

Rp217.87B ÷ Rp419.21B ≈ 52.0%

A payout ratio around 52% is neither extremely conservative nor excessively aggressive.

It leaves roughly half of annual attributable earnings available for retained earnings, working capital, debt management, and investment.

What Would the Dividend Yield Look Like?

As a valuation illustration, WIIM traded around Rp1,820 per share in a market quotation reported by IDNFinancials in June 2026.

Using the Rp104.4 dividend:

Dividend yield = Rp104.4 ÷ Rp1,820 ≈ 5.74%

That is potentially attractive for an income-oriented investor.

However, this should not be interpreted as today's guaranteed dividend yield. Stock prices change every trading day, and the Rp104.4 dividend relates specifically to fiscal 2025.

For U.S. investors, currency movements also matter. A 5.7% dividend yield in Indonesian rupiah can produce a different return when converted into U.S. dollars.

Valuation: Is WIIM Cheap?

Using the illustrative Rp1,820 share price and 2025 EPS of approximately Rp201.77:

P/E ≈ 9.0x

Using 2025 equity attributable to the parent company of approximately Rp2.213 trillion and approximately 2.10 billion shares:

Book value per share ≈ Rp1,054

At Rp1,820:

P/B ≈ 1.73x

This creates an interesting valuation profile.

WIIM would not necessarily qualify as a deep-value stock because investors are paying more than book value.

But a P/E around 9x combined with approximately 40% EPS growth and a dividend yield around 5–6% can look attractive if earnings remain durable.

The problem is that investors should not extrapolate 2025's 40% earnings growth indefinitely.

That would be an overly optimistic assumption.

Return on Equity

Using 2025 attributable earnings of approximately Rp419.2 billion and average equity attributable to the parent company between 2024 and 2025:

Average equity ≈ (Rp1.914T + Rp2.213T) ÷ 2

≈ Rp2.064T

Estimated ROE:

Rp419.2B ÷ Rp2.064T ≈ 20.3%

An ROE above 20% is a strong result.

It suggests Wismilak generated a meaningful return on shareholder capital during 2025.

However, investors should examine whether that ROE can remain above 15–20% over a full business cycle rather than judging the company from one exceptional year.

The Biggest Risk: Tobacco Regulation

The biggest structural risk is not Wismilak's balance sheet.

It is the tobacco industry's regulatory environment.

Indonesia has implemented tobacco-excise policies intended to control consumption while also considering the economic importance of the tobacco manufacturing sector. Indonesia's Ministry of Finance has amended cigarette excise and retail-price regulations, including PMK 97/2024 for tobacco products.

For cigarette manufacturers, excise taxes can significantly influence:

retail prices;
consumer affordability;
product mix;
margins;
volume;
downtrading behavior; and
demand for lower-priced cigarettes.

Therefore, a major risk for WIIM shareholders is that future tax or retail-price policies could reduce volumes or compress margins.

Tobacco Demand Remains Large — But Public-Health Risk Is Significant

The long-term demand picture is complicated.

According to the World Health Organization's 2025 Indonesia tobacco profile, approximately 29.4% of adults aged 15 and above were current cigarette smokers based on the latest national survey data cited by WHO. Among men, the current cigarette-smoking prevalence was approximately 57.3%.

That indicates a large domestic addressable market.

But it also highlights the fundamental contradiction facing tobacco companies.

High smoking prevalence supports current demand, while public-health policies are designed to reduce tobacco consumption over time.

For long-term investors, WIIM should therefore be treated as a company operating in a structurally regulated and potentially declining-category industry, even if individual companies can still grow market share.

Why 2025 Growth Matters

The most interesting part of WIIM's investment story is that the company managed to grow despite these structural challenges.

In 2024, net sales declined approximately 2.54%, while net income declined almost 40%.

In 2025, the pattern reversed:

Revenue: +34%
Operating income: +48%
Net income attributable to parent: +40%
EPS: +40%
Operating cash flow: more than doubled

That suggests Wismilak has demonstrated an ability to adapt its product mix and distribution strategy.

The question is whether 2025 was the beginning of a sustainable earnings cycle or simply a particularly strong rebound year.

2026: What Investors Should Watch

The company's investor-relations page now lists an interim consolidated financial statement for June 30, 2026, indicating that the latest half-year financial reporting is available from the company.

Investors should focus on five indicators when evaluating the 2026 results:

1. Revenue growth

If sales continue growing at double-digit rates, the 2025 recovery may have further room to run.

2. Gross margin

Revenue growth is less valuable if higher excise taxes and raw-material costs consume the additional revenue.

3. SKM performance

Machine-rolled cigarettes were a major contributor to 2025 growth. Investors should determine whether this segment continues to gain momentum.

4. Operating cash flow

Cash generation should ideally grow alongside reported earnings.

5. Inventory

Inventory was approximately Rp1.83 trillion at the end of 2025. Investors should watch whether inventory grows faster than revenue.

WIIM vs. a Typical U.S. Tobacco Stock

An American investor may naturally compare WIIM with companies such as Altria or Philip Morris International.

But the comparison should be approached carefully.

Factor	WIIM	Large U.S./Global Tobacco Companies
Primary market	Indonesia	U.S./Global
Currency	IDR	USD/other major currencies
Market capitalization	Smaller	Much larger
Regulatory exposure	Indonesia	U.S./multiple countries
Dividend profile	Potentially attractive	Often mature/high payout
Growth profile	Higher potential	Generally more mature
Liquidity	Lower	Generally much higher
Emerging-market risk	High	Lower
Currency risk for U.S. investor	High	Lower for U.S.-listed stocks
Tobacco-category risk	High	High

WIIM's smaller size can be both an advantage and a disadvantage.

A smaller company can grow faster because it has a smaller base.

But its shares may also have lower liquidity and greater price volatility.

Key Bull Case

The bullish investment thesis for WIIM rests on several factors.

First, earnings momentum is strong.

Net income attributable to shareholders increased approximately 40% in 2025.

Second, margins improved.

Operating income grew faster than revenue.

Third, leverage is manageable.

The company reported a 0.45x debt-to-equity ratio at the end of 2025.

Fourth, cash flow improved materially.

Operating cash flow increased from approximately Rp157 billion to Rp362.5 billion.

Fifth, shareholders received a meaningful dividend.

The 2025 dividend was Rp104.4 per share.

Together, these characteristics create a potentially attractive small-cap value-and-income story.

Key Bear Case

The bearish case is equally important.

Tobacco regulation

Higher excise taxes or stricter regulations could reduce affordability and volumes.

Consumer downtrading

Consumers may switch toward lower-priced tobacco products if cigarette prices rise.

Raw-material inflation

Tobacco, cloves, packaging and other production inputs can pressure gross margins.

Currency risk

A U.S. investor buying an Indonesian stock is exposed to the Indonesian rupiah.

Even if WIIM rises 10% in IDR terms, the investor's USD return could be lower if the rupiah depreciates.

Emerging-market liquidity

WIIM is much less liquid than major U.S.-listed tobacco stocks.

Category risk

The long-term global direction of tobacco regulation remains unfavorable from a public-health perspective.

A Simple 2026 Valuation Scenario

Rather than predicting one exact target price, investors can build a scenario analysis.

Suppose 2025 EPS was approximately Rp201.77.

Bear Case

Assume EPS falls 10%:

EPS ≈ Rp181.6

At a 7x P/E:

Estimated value ≈ Rp1,271

Base Case

Assume EPS grows 10%:

EPS ≈ Rp221.9

At a 9x P/E:

Estimated value ≈ Rp1,997

Bull Case

Assume EPS grows 20%:

EPS ≈ Rp242.1

At a 11x P/E:

Estimated value ≈ Rp2,663

These are illustrative valuation scenarios, not price targets or investment recommendations.

The exercise demonstrates why investors should focus on both earnings growth and valuation multiples.

A company can grow earnings and still produce mediocre shareholder returns if investors pay too high a valuation.

What Would Make WIIM More Attractive?

For a long-term investor, the investment case becomes stronger if the company can demonstrate:

Sustained double-digit revenue growth.
Stable or expanding gross margins.
EPS growth above inflation.
Operating cash flow consistently close to or above net income.
Controlled inventory growth.
Moderate leverage.
Sustainable dividend payments.
Continued market-share gains in key cigarette categories.

If those conditions persist, a P/E below approximately 10x could potentially provide an attractive risk/reward profile.

What Would Make WIIM Less Attractive?

The thesis becomes weaker if:

revenue growth falls sharply;
cigarette volumes decline;
excise-tax increases exceed the company's pricing power;
gross margins contract;
inventory rises faster than sales;
operating cash flow deteriorates;
debt increases materially; or
dividend payments become dependent on borrowing.

These indicators are arguably more important than short-term share-price movements.

Final Verdict: Is Wismilak Inti Makmur Stock Worth Watching?

WIIM is an interesting emerging-market tobacco stock, but it is not a low-risk investment.

The 2025 financial results were impressive.

Revenue increased approximately 34%, operating income increased approximately 48%, and net income attributable to shareholders increased approximately 40%. The company also strengthened its equity base and generated substantially more operating cash flow.

At an illustrative share price of Rp1,820, the 2025 results imply a P/E of roughly 9x and a dividend yield of approximately 5.7% based on the Rp104.4 fiscal-2025 dividend.

Those numbers make WIIM potentially attractive to value-oriented and dividend-oriented investors who are comfortable with emerging-market and tobacco-sector risks.

However, U.S. investors should not assume that 2025's 40% earnings growth will continue indefinitely.

The more realistic investment thesis is:

WIIM may offer an attractive combination of moderate valuation, improving profitability, and dividends, but the stock remains exposed to Indonesia's tobacco regulation, currency risk, industry taxation, consumer behavior, and emerging-market volatility.

For a U.S. investor, WIIM is therefore better viewed as a higher-risk satellite position rather than a core portfolio holding.

The company deserves further monitoring, particularly through its 2026 interim results. If earnings growth, cash generation and margins remain strong while valuation stays reasonable, the stock could continue to offer an interesting risk/reward profile.

Investor Checklist for WIIM

Before buying WIIM, investors should review:

Important Disclaimer

This article is for educational and informational purposes only and does not constitute investment advice, a recommendation to buy or sell WIIM, or an offer to purchase securities.

WIIM is listed on the Indonesia Stock Exchange, not a major U.S. stock exchange. U.S. investors should consider brokerage access, foreign-exchange costs, taxation, liquidity, political/regulatory risk, and the possibility that Indonesian securities may not provide the same investor protections or liquidity as U.S.-listed securities.

Financial data in this analysis primarily comes from Wismilak's audited consolidated financial statements and official investor disclosures.

Primary and Credible Sources

PT Wismilak Inti Makmur Tbk — Investor Relations / Annual & Financial Reports
Wismilak Investor Relations

The company's investor-relations page provides its annual reports, audited financial statements, interim reports, sustainability reports and other investor disclosures.

Wismilak 2025 Audited Consolidated Financial Statements
Wismilak 2025 Consolidated Financial Statements

This is the primary source for the 2025 income statement, balance sheet, cash flow statement, EPS, debt and equity figures used in this article.

Wismilak 2025 Sustainability Report
Wismilak 2025 Sustainability Report

This provides additional information about sales volumes, product segments and economic value generated in 2025.

Wismilak 2026 Dividend Disclosure
Wismilak 2025 Fiscal-Year Dividend Announcement

The official announcement states that the company would distribute Rp217.87 billion, or Rp104.4 per share, for fiscal 2025.

Indonesia Ministry of Finance — Tobacco Excise Regulations
Ministry of Finance JDIH — PMK 97/2024

This is a primary government source for Indonesia's tobacco-excise and retail-price framework.

World Health Organization — Indonesia Tobacco Profile 2025
WHO Indonesia Tobacco Country Profile 2025

WHO data provides independent context on smoking prevalence and the public-health environment surrounding Indonesia's tobacco industry.

About the Author

David Mulyana is the founder and editor of WorldReview1989, an independent publication dedicated to finance, investing, insurance, business, technology, and digital marketing.

He researches and writes in-depth articles that help readers understand complex financial topics through clear explanations, practical insights, and data-driven analysis. His editorial focus includes stock market investing, cryptocurrencies, banking, personal finance, business insurance, real estate, startup strategies, and emerging technology trends.

Every article published on WorldReview1989 is created with a commitment to accuracy, transparency, and reader value. Content is reviewed regularly to reflect the latest market developments, industry updates, and publicly available information from trusted sources.

Editorial Principles

- Accuracy before speed
- Independent and unbiased analysis
- Clear, easy-to-understand explanations
- Information supported by reputable public sources
- Regular updates to maintain content relevance

Areas of Expertise

- Personal Finance
- Investing & Stock Market
- Cryptocurrency & Blockchain
- Insurance
- Banking
- Real Estate
- Business & Entrepreneurship
- Digital Marketing
- Financial Technology (FinTech)

About WorldReview1989

WorldReview1989 provides educational content for readers seeking reliable information about finance, investment opportunities, insurance, business strategies, and technology. The website aims to simplify complex financial concepts and empower readers to make informed decisions.

Disclaimer: The information published on WorldReview1989 is for educational and informational purposes only. It should not be considered financial, legal, tax, or investment advice. Readers should consult qualified professionals before making financial decisions.
David Mulyana writes about stocks, financial markets, investment strategies, insurance and emerging-market opportunities, with a focus on helping readers understand financial data and investment risks